ProSomnus® Sleep Technologies

ProSomnus® Sleep Technologies is a publicly traded medical device company founded in 2016. It specializes in developing and manufacturing precision, mass-customized oral appliance therapy (OAT) devices for treating Obstructive Sleep Apnea (OSA). The company is recognized as a leader in non-CPAP OSA therapy, providing patient-preferred oral appliances that help reposition and stabilize the jaw during sleep to enhance airway airflow. The flagship product line includes the ProSomnus® [IA] (Iterative Advancement) devices, which are FDA-cleared and designed using a patented precision manufacturing process. These devices feature customizable mandibular advancement options and are designed for comfort and effectiveness. ProSomnus serves over 4,000 dental and medical providers, having prescribed more than 175,000 devices to date. The company emphasizes innovation and personalized device customization to improve treatment experiences for patients with OSA. Led by Co-Founder and CEO Len Liptak and Co-Founder and CTO Sung Kim, ProSomnus is committed to expanding its clinical research efforts to validate and enhance its therapies globally.

• Employees 140
• Founded 2016
• Annual Revenue $27652000
• Total Funding $49175000